764 / 1609
10-Year Results of the Randomized Boost Versus
No Boost EORTC 22881-10882 Trial
5318 patients T1-2 free margins.
Bartelink H et al. J Clin Oncol 2007;25:3259-65
10.2%
6.2%
Local recurrence depends on the dose
|
|
764 / 1609
10-Year Results of the Randomized Boost Versus
No Boost EORTC 22881-10882 Trial
5318 patients T1-2 free margins.
Bartelink H et al. J Clin Oncol 2007;25:3259-65
10.2%
6.2%
Local recurrence depends on the dose